- Investing.com
Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry-sponsored research. The company also designs and provides quality assurance services in clinical trials, focused on the administration, scoring and recording of conventional brain health assessments. In addition, the company offers cognitive services including project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. Further, it provides Cognigram, a computerized test to aid healthcare professionals with cognitive decline. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Metrics to compare | CGS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCGSPeersSector | |
---|---|---|---|---|
P/E Ratio | 19.6x | −2.9x | −0.6x | |
PEG Ratio | 0.23 | −0.02 | 0.00 | |
Price/Book | 4.2x | 1.6x | 2.6x | |
Price / LTM Sales | 3.8x | 2.0x | 3.3x | |
Upside (Analyst Target) | 21.7% | 92.3% | 39.0% | |
Fair Value Upside | Unlock | 16.5% | 4.9% | Unlock |